Clinical Trials Directory

Trials / Completed

CompletedNCT00804505

Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study

A 90 Day Multi-Center, Randomized, Parallel Group Daily Wear Investigation of a New Hybrid Lens SynergEyes SA Manufactured With a Rigid Gas Permeable Center (Petrafocon A) and a Silicone Hydrogel Skirt (Larafilcon A) Compared to SynergEyes A (Paflufocon D Hem-iberfilcon A)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
98 (actual)
Sponsor
SynergEyes, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to demonstrate that the SynergEyes SA Hybrid Contact Lens clinical performance is substantially equivalent to that of the SynergEyes A Hybrid Lens when studied: * within the corresponding range of lens powers * in a population randomized within multiple investigational sites * with a study ration of 2/1 test vs control lenses * for a duration of 90 days.

Detailed description

The objective of the study is to compare the SynergEyes SA Hybrid Contact Lens (Test) to the SynergEyes A Hybrid Contact lens (Control) when used in a daily wear regimen on non-diseased eyes for the correction of myopia (-0.25 to -6.00Diopters) with up to -2.50 Diopters of astigmatism. The population will be randomized into a 2/1 ratio of the Test/Control for 90 days. The study objective is to complete at least 40 subjects in the Test material and 20 subjects in the Control material. The purpose of the study is to demonstrate that the SynergEyes SA Hybrid Contact Lens clinical performance is substantially equivalent to that of the SynergEyes A Hybrid Lens when studied within the corresponding range of powers in a population randomized within investigational sites to produce a 2/1 ratio of Test vs. Control lenses.

Conditions

Interventions

TypeNameDescription
DEVICESynergEyes Hybrid (petrafocon A hem-larafilcon A) Hybrid Contact LensComparison to control hybrid lens with similar 'dose'minimum 8 hours daily use for up to 90 days.
DEVICESynergEyes Hybrid (paflufocon D hem-iberfilcon A) Contact LensComparison to test lens: Daily use for minimum 8 hours up to 90 days.

Timeline

Start date
2008-06-01
Primary completion
2008-11-01
Completion
2008-12-01
First posted
2008-12-09
Last updated
2009-12-23

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00804505. Inclusion in this directory is not an endorsement.